Author: Parra-Lara, Luis Gabriel; MartÃnez-Arboleda, Juan José; Rosso, Fernando
Title: Azithromycin and SARS-CoV-2 infection: where we are now and where we are going Cord-id: mjy4culg Document date: 2020_7_1
ID: mjy4culg
Snippet: • Due to its mechanism of action and various anti-inflammatory effects, azithromycin is a promising medicine for the treatment of the coronavirus COVID-19. • The studies that have been done so far on the use of azithromycin in the management of the COVID-19 coronavirus have had various methodological limitations. At the moment, no conclusions can be drawn about the efficacy of this drug as an adjunct to hydroxychloroquine. • Azithromycin has serious cardiac adverse effects such as QT prolo
Document: • Due to its mechanism of action and various anti-inflammatory effects, azithromycin is a promising medicine for the treatment of the coronavirus COVID-19. • The studies that have been done so far on the use of azithromycin in the management of the COVID-19 coronavirus have had various methodological limitations. At the moment, no conclusions can be drawn about the efficacy of this drug as an adjunct to hydroxychloroquine. • Azithromycin has serious cardiac adverse effects such as QT prolongation. Hydroxychloroquine also has them. The combination of these two drugs should be determined with caution. • At the moment 21 clinical trials are being carried out on the use of azithromycin in COVID-19.
Search related documents:
Co phrase search for related documents- additive effect and low frequency: 1
- additive effect and macrolide antibiotic: 1
- adhesion molecule and low frequency: 1
Co phrase search for related documents, hyperlinks ordered by date